No Data
No Data
Werewolf Therapeutics Reports Q4 EPS (46c), Consensus (31c)
Werewolf Therapeutics Sees Cash Runway Through 2Q26
Werewolf Therapeutics | 10-K: Annual report
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Express News | Werewolf Therapeutics Q4 Net Income USD -20.4 Million
Express News | Werewolf Therapeutics Q4 Operating Expenses USD 20.348 Million